Literature DB >> 8325982

Expression of 92-kD type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1.

M Mohtai1, R L Smith, D J Schurman, Y Tsuji, F M Torti, N I Hutchinson, W G Stetler-Stevenson, G I Goldberg.   

Abstract

We report here that a 92-kD gelatinolytic metalloproteinase is expressed as protein and mRNA in human osteoarthritic cartilage, but not in normal adult articular cartilage. Western immunoblotting demonstrated that the 92-kD gelatinolytic activity corresponded to 92-kD type IV collagenase/gelatinase (gelatinase B); mRNA for gelatinase B was identified by Northern blotting. Chondrocytes from normal cartilage also exhibited mRNA for 72-kD type IV collagenase/gelatinase (gelatinase A), tissue collagenase, and stromelysin-1, and these mRNAs were increased in osteoarthritic cartilage. Regional analysis of osteoarthritic cartilage samples from four individuals revealed that gelatinase B mRNA was expressed in grossly fibrillated areas; two of four nonfibrillated cartilage samples failed to exhibit the mRNA, but did have increased levels of mRNA for other neutral metalloproteinases. IL-1 alpha treatment of normal human cartilage explants or isolated chondrocytes induced increased levels of gelatinase B and increased mRNA for tissue collagenase and stromelysin-1. Under identical conditions, mRNA levels for gelatinase A were not increased indicating that regulation of this enzyme in human articular chondrocytes is distinct from that of other metalloproteinases. Our data showing expression of gelatinase B in fibrillated cartilage suggest that it is a marker of progressive articular cartilage degradation in osteoarthritis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8325982      PMCID: PMC293560          DOI: 10.1172/JCI116547

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

1.  A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization.

Authors:  Y Okada; H Nagase; E D Harris
Journal:  J Biol Chem       Date:  1986-10-25       Impact factor: 5.157

2.  Human monocyte or recombinant interleukin 1's are specific for the secretion of a metalloproteinase from chondrocytes.

Authors:  J Schnyder; T Payne; C A Dinarello
Journal:  J Immunol       Date:  1987-01-15       Impact factor: 5.422

3.  'Gelatinase-like' activity from articular chondrocytes in monolayer culture.

Authors:  A I Sapolsky; M F Sheff; K Matsuta; D S Howell; R W Moskowitz; V M Goldberg; D P Norby; C J Malemud
Journal:  Biochim Biophys Acta       Date:  1983-04-05

4.  Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase.

Authors:  M S Hibbs; K A Hasty; J M Seyer; A H Kang; C L Mainardi
Journal:  J Biol Chem       Date:  1985-02-25       Impact factor: 5.157

5.  Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein.

Authors:  G I Goldberg; S M Wilhelm; A Kronberger; E A Bauer; G A Grant; A Z Eisen
Journal:  J Biol Chem       Date:  1986-05-15       Impact factor: 5.157

6.  Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties.

Authors:  Y Okada; Y Gonoji; K Naka; K Tomita; I Nakanishi; K Iwata; K Yamashita; T Hayakawa
Journal:  J Biol Chem       Date:  1992-10-25       Impact factor: 5.157

7.  Articular cartilage cultured with catabolin (pig interleukin 1) synthesizes a decreased number of normal proteoglycan molecules.

Authors:  J A Tyler
Journal:  Biochem J       Date:  1985-05-01       Impact factor: 3.857

8.  Stromelysin, a connective tissue-degrading metalloendopeptidase secreted by stimulated rabbit synovial fibroblasts in parallel with collagenase. Biosynthesis, isolation, characterization, and substrates.

Authors:  J R Chin; G Murphy; Z Werb
Journal:  J Biol Chem       Date:  1985-10-05       Impact factor: 5.157

9.  Isolation of the oncogene and epidermal growth factor-induced transin gene: complex control in rat fibroblasts.

Authors:  L M Matrisian; P Leroy; C Ruhlmann; M C Gesnel; R Breathnach
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

10.  Epidermal growth factor and oncogenes induce transcription of the same cellular mRNA in rat fibroblasts.

Authors:  L M Matrisian; N Glaichenhaus; M C Gesnel; R Breathnach
Journal:  EMBO J       Date:  1985-06       Impact factor: 11.598

View more
  27 in total

1.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis.

Authors:  Y Yoshihara; H Nakamura; K Obata; H Yamada; T Hayakawa; K Fujikawa; Y Okada
Journal:  Ann Rheum Dis       Date:  2000-06       Impact factor: 19.103

2.  Gene expression of matrix metalloproteinases 1, 3, and 9 by chondrocytes in osteoarthritic human knee articular cartilage is zone and grade specific.

Authors:  A J Freemont; V Hampson; R Tilman; P Goupille; Y Taiwo; J A Hoyland
Journal:  Ann Rheum Dis       Date:  1997-09       Impact factor: 19.103

3.  Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage.

Authors:  K Imai; S Ohta; T Matsumoto; N Fujimoto; H Sato; M Seiki; Y Okada
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

4.  Complement C1s activation in degenerating articular cartilage of rheumatoid arthritis patients: immunohistochemical studies with an active form specific antibody.

Authors:  K Nakagawa; H Sakiyama; T Tsuchida; K Yamaguchi; T Toyoguchi; R Masuda; H Moriya
Journal:  Ann Rheum Dis       Date:  1999-03       Impact factor: 19.103

5.  Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration.

Authors:  A P Hollander; I Pidoux; A Reiner; C Rorabeck; R Bourne; A R Poole
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

Review 6.  Crystal deposition and osteoarthritis.

Authors:  N Olmez; H R Schumacher
Journal:  Curr Rheumatol Rep       Date:  1999-12       Impact factor: 4.592

7.  Treatment with ephrin B2 positively impacts the abnormal metabolism of human osteoarthritic chondrocytes.

Authors:  Steeve Kwan Tat; Jean-Pierre Pelletier; Nathalie Amiable; Christelle Boileau; Martin Lavigne; Johanne Martel-Pelletier
Journal:  Arthritis Res Ther       Date:  2009-08-07       Impact factor: 5.156

8.  Differential expression patterns of matrix metalloproteinases and their inhibitors during development of osteoarthritis in a transgenic mouse model.

Authors:  H J Salminen; A-M K Säämänen; M N Vankemmelbeke; P K Auho; M P Perälä; E I Vuorio
Journal:  Ann Rheum Dis       Date:  2002-07       Impact factor: 19.103

Review 9.  Which elements are involved in reversible and irreversible cartilage degradation in osteoarthritis?

Authors:  Anne-Christine Bay-Jensen; Suzi Hoegh-Madsen; Erik Dam; Kim Henriksen; Bodil Cecillie Sondergaard; Philippe Pastoureau; Per Qvist; Morten A Karsdal
Journal:  Rheumatol Int       Date:  2009-10-09       Impact factor: 2.631

10.  Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay.

Authors:  A P Hollander; T F Heathfield; C Webber; Y Iwata; R Bourne; C Rorabeck; A R Poole
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.